Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

gallium Ga 68-edotreotide

A radioconjugate consisting of the octreotide derivative edotreotide labeled with gallium 68 (Ga-68) with potential application in somatostatin receptor (SSTR) imaging in conjunction with positron emission tomography (PET). Similar to octreotide, gallium Ga 68-edotreotide binds to SSTRs, especially type 2 receptors, present on the cell membranes of many types of neuroendocrine tumor cells and their metastases, thereby allowing for imaging of SSTR-expressing cells upon PET. Gallium Ga 68-edotreotide is produced by substituting tyrosine for phenylalanine at the 3 position of the somatostatin analogue octreotide (Tyr3-octreotide or TOC) and chelating the substituted octreotide to Ga-68 via the macrocyclic chelating agent dodecanetetraacetic acid (DOTA).
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:68Ga-DOTA-d-Phe1-Tyr3-octreotide
68Ga-DOTA-TOC
Ga-68 DOTA0-Tyr3-octreotide
Ga-68 DOTATOC
Ga-68-[Tyr3]-octreotide
Ga-68-DOTA-TOC
Ga-68-DOTA-tyr(3)-octreotide
gallium Ga 68-DOTATOC
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search